JMJD4 Antibody (D-10): sc-514881. Western blot analysis of JMJD4 expression in SK-BR-3 (A), NIH/3T3 (B), M1 (C) and RPE-J (D) whole cell lysates and rat thymus tissue extract (E).
Not CRISPR data: the image illustrates antibody quality for visualizing CRISPR experiment results.
JMJD4 Antibody (D-10): sc-514881. Western blot analysis of JMJD4 expression in SK-BR-3 (A), NIH/3T3 (B), M1 (C) and RPE-J (D) whole cell lysates and rat thymus tissue extract (E).
Not CRISPR data: the image illustrates antibody quality for visualizing CRISPR experiment results.
20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
JMJD4 CRISPR/Cas9 Knockout (KO) Plasmid (h) is a pool of plasmids, each encoding Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed for maximum knockout efficiency using sequences derived from the GeCKO v2 library
gRNA sequences direct Cas9 to induce site-specific double-strand breaks (DSBs) in the JMJD4 genomic locus, resulting in gene knockout through non-homologous end joining (NHEJ)
The puromycin resistance and RFP genes are flanked by LoxP sites, enabling removal of selection markers via Cre recombinase (Cre Vector: sc-418923) after establishing stable knockout cell lines
Following transfection, gene knockout efficiency can be assayed by WB, IF or IHC using antibody: JMJD4 Antibody (D-10): sc-514881